Phase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Vaccine Against Respiratory Syncytial Virus

Clinical trial NCT04519073 · COMPLETED

Trial details

NCT number: NCT04519073
Sponsor: Virometix
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Bronchiolitis Due to Respiratory Syncytial Virus

Start date: 2020-09-07
Primary completion: 2022-03-02
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.